Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations
<p>Abstract</p> <p>Background</p> <p>In Central and South America and Eastern and Southern Africa, <it>Plasmodium vivax </it>infections accounts for 71-81% and 5% of malaria cases, respectively. In these areas, chloroquine (CQ) remains the treatment of choic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-08-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/10/1/249 |